Association of copayment and statin adherence stratified by socioeconomic status

scientific article published on 10 October 2013

Association of copayment and statin adherence stratified by socioeconomic status is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1060028013505743
P698PubMed publication ID24259605
P5875ResearchGate publication ID258825083

P50authorMark BounthavongQ55362991
Rashid KazerooniQ56999281
P2093author name stringJonathan H Watanabe
P2860cites workHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationQ22306356
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsQ29547856
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsQ29547887
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention StudyQ29617822
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study GroupQ29619842
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsQ29620696
Does medication adherence lower Medicare spending among beneficiaries with diabetes?Q35089645
Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristicsQ35825588
Effects of increased patient cost sharing on socioeconomic disparities in health careQ36840933
The demand for statin: the effect of copay on utilization and compliance.Q36856495
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.Q37365655
Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetesQ37394557
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experimentQ42616762
The effect of a large regional health plan's value-based insurance design program on statin use.Q42671804
Effect of increased copayments on pharmacy use in the Department of Veterans AffairsQ45332124
Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.Q51719123
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectsocioeconomicsQ1643441
P304page(s)1463-1470
P577publication date2013-10-10
P1433published inAnnals of PharmacotherapyQ4767858
P1476titleAssociation of copayment and statin adherence stratified by socioeconomic status
P478volume47

Reverse relations

cites work (P2860)
Q61956042Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel
Q38752985Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients
Q90106686Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study
Q35158704Optimizing enrollment in employer health programs: a comparison of enrollment strategies in the Diabetes Health Plan
Q37167826Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care

Search more.